Logo image of WRD

WERIDE INC-ADR (WRD) Stock Fundamental Analysis

NASDAQ:WRD - Nasdaq - US9509151083 - ADR - Currency: USD

9.3802  +0.28 (+3.08%)

Fundamental Rating

3

Overall WRD gets a fundamental rating of 3 out of 10. We evaluated WRD against 80 industry peers in the Automobile Components industry. While WRD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, WRD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WRD has reported negative net income.
WRD had a negative operating cash flow in the past year.
WRD Yearly Net Income VS EBIT VS OCF VS FCFWRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

The Return On Assets of WRD (-32.71%) is worse than 92.50% of its industry peers.
WRD's Return On Equity of -35.62% is on the low side compared to the rest of the industry. WRD is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
ROA -32.71%
ROE -35.62%
ROIC N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRD Yearly ROA, ROE, ROICWRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

With an excellent Gross Margin value of 30.66%, WRD belongs to the best of the industry, outperforming 88.75% of the companies in the same industry.
In the last couple of years the Gross Margin of WRD has declined.
WRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
WRD Yearly Profit, Operating, Gross MarginsWRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

WRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WRD has more shares outstanding
Compared to 1 year ago, WRD has a worse debt to assets ratio.
WRD Yearly Shares OutstandingWRD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M 250M
WRD Yearly Total Debt VS Total AssetsWRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 16.26 indicates that WRD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 16.26, WRD belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
WRD has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of WRD (0.01) is better than 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 16.26
ROIC/WACCN/A
WACC8.11%
WRD Yearly LT Debt VS Equity VS FCFWRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

WRD has a Current Ratio of 13.43. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 13.43, WRD belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.
WRD has a Quick Ratio of 13.06. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.06, WRD belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.43
Quick Ratio 13.06
WRD Yearly Current Assets VS Current LiabilitesWRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for WRD have decreased strongly by -26.57% in the last year.
Looking at the last year, WRD shows a very negative growth in Revenue. The Revenue has decreased by -10.13% in the last year.
Measured over the past years, WRD shows a very strong growth in Revenue. The Revenue has been growing by 37.75% on average per year.
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, WRD will show a very strong growth in Earnings Per Share. The EPS will grow by 28.35% on average per year.
WRD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 212.08% yearly.
EPS Next Y4.96%
EPS Next 2Y16.24%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue Next Year117.08%
Revenue Next 2Y163.12%
Revenue Next 3Y212.08%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WRD Yearly Revenue VS EstimatesWRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B
WRD Yearly EPS VS EstimatesWRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRD Price Earnings VS Forward Price EarningsWRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRD Per share dataWRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

WRD's earnings are expected to grow with 28.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.24%
EPS Next 3Y28.35%

More info and screens

0

5. Dividend

5.1 Amount

WRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WERIDE INC-ADR

NASDAQ:WRD (7/21/2025, 11:57:10 AM)

9.3802

+0.28 (+3.08%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-21 2025-05-21
Earnings (Next)N/A N/A
Inst Owners1.87%
Inst Owner Change14.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.57B
Analysts80
Price Target16.32 (73.98%)
Short Float %3.75%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-15.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-46.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 51.18
P/FCF N/A
P/OCF N/A
P/B 2.62
P/tB 2.64
EV/EBITDA N/A
EPS(TTM)-1.49
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.18
BVpS3.59
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.71%
ROE -35.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.66%
FCFM N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.55%
Cap/Sales 23.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.43
Quick Ratio 13.06
Altman-Z 16.26
F-Score3
WACC8.11%
ROIC/WACCN/A
Cap/Depr(3y)101.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y4.96%
EPS Next 2Y16.24%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year117.08%
Revenue Next 2Y163.12%
Revenue Next 3Y212.08%
Revenue Next 5YN/A
EBIT growth 1Y-39.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.74%
EBIT Next 3Y29.39%
EBIT Next 5YN/A
FCF growth 1Y-32.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25%
OCF growth 3YN/A
OCF growth 5YN/A